Skip to main content
Caplight Logo









Ordaos Bio

Ordaos Bio

Private
New York City, New YorkHealthcare & Life Scienceshttps://ordaos.bio/

Last Round

Accelerator

May 31, 2023

Total Funding Raised

$5.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ordaos Bio is a biotechnology company that utilizes a human-enabled, machine-driven drug design platform to create novel mini-proteins for therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

generative AIdrug discoveryde novo protein designmini-proteinsbiotech AIin silico drug designprotein engineeringAI drug discoverybiologicstherapeutic candidatesreinforcement learningmeta-learningprecision medicinedrug developmentAI-native biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ordaos Bio Comparables

Compare Ordaos Bio with similar companies based on industry and business-model similarity.

Ordaos Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nabla Bio
85%
AI Proteins
84%
DenovAI Biotech
82%

Ordaos Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 31, 2023
SeedAug 25, 2022

Ordaos Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 154% MoM, reaching 2K.

  • Jun 18, 2026

    Monthly visitors grew 36% MoM, reaching 1.4K.

Ordaos Bio Filings

Explore SEC and related filing metadata, where available.

Ordaos Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ordaos Bio's valuation, stock price, and market status.

Is Ordaos Bio a public or private company?

Ordaos Bio is a private company.

What is the current stock price of Ordaos Bio?

Ordaos Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Ordaos Bio worth (valuation)?

Valuation information for Ordaos Bio is not publicly available.

Can I buy Ordaos Bio stock?

Ordaos Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ordaos Bio's last funding round?

Ordaos Bio's most recent funding round was Seed on August 25, 2022.

Who are the main investors in Ordaos Bio?

Key investors in Ordaos Bio include IAG Capital Partners, Citta Capital, Route 66 Ventures, Banyan Pacific Capital, House Capital.

Will Ordaos Bio IPO soon?

No public IPO plans have been announced for Ordaos Bio.

How can I track Ordaos Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ordaos Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range21
Year Founded2019
Last FundingMay 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?